Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Sodium bicarbonate
Drug ID BADD_D02034
Description Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.
Indications and Usage Sodium bicarbonate is used for the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturateprotein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments.
Marketing Status approved
ATC Code B05CB04; B05XA02
DrugBank ID DB01390
KEGG ID D01203
MeSH ID D017693
PubChem ID 516892
TTD Drug ID D02FLB
NDC Product Code 77333-827; 10237-595; 49452-6611; 10135-684; 10135-685; 70491-105; 51662-1400; 55681-307; 63323-083; 82645-904; 90107-1103; 52946-0929; 24286-1523; 24286-1537; 54738-020; 63629-8775; 64980-528; 0395-2685; 70369-002; 70795-1180; 72572-740; 10237-593; 49452-6610; 52682-206; 63323-089; 0409-6625; 0409-6637; 70795-1130; 71872-7247; 69367-258; 76328-223; 76329-3352; 10237-594; 10237-598; 83094-102; 51662-1383; 51754-5002; 51754-5012; 52584-096; 0409-4900; 0409-5555; 71610-438; 76328-221; 77333-831; 51754-5001; 51754-5011; 54738-035; 0409-4916; 70795-1190; 0802-2685; 90107-1280; 10106-3509; 10237-590; 10237-592; 51552-0059; 58989-001; 43353-041; 43353-162; 53145-300; 0404-9951; 0404-9980; 70369-001; 0536-1046; 0536-1047; 71610-669; 71872-7097; 24689-137; 51662-1255; 55758-319; 64980-294; 0404-9985; 71872-7266; 81665-200; 10095-100; 70491-102; 44224-1040; 52584-099; 0409-5534; 90107-1030; 10237-596; 10237-597; 0904-7261; 10237-591; 71901-604; 0404-9950; 0404-9984; 83094-105; 51662-1497; 51662-1573; 55681-331; 57896-676
UNII 8MDF5V39QO
Synonyms Sodium Bicarbonate | Bicarbonate, Sodium | Carbonic Acid Monosodium Salt | Sodium Hydrogen Carbonate | Hydrogen Carbonate, Sodium | Baking Soda | Soda, Baking
Chemical Information
Molecular Formula NaHCO3
CAS Registry Number 144-55-8
SMILES C(=O)(O)[O-].[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Injection site discomfort12.07.03.019; 08.02.03.0180.004356%Not Available
Haemorrhage24.07.01.0020.000854%Not Available
Acute kidney injury20.01.03.0160.001495%
Injury associated with device12.01.08.035; 08.07.01.0120.002904%Not Available
Drug reaction with eosinophilia and systemic symptoms12.03.01.064; 23.03.05.005; 10.01.01.0210.000641%Not Available
Administration site discomfort08.02.04.010; 12.07.04.0100.001452%Not Available
Multiple organ dysfunction syndrome08.01.03.0570.000427%
Administration site pain12.07.04.029; 08.02.04.0290.002904%Not Available
Injection site hypoaesthesia08.02.03.060; 17.02.06.051; 12.07.03.0600.000427%Not Available
Intravascular papillary endothelial hyperplasia16.02.01.010; 24.03.06.0140.000427%Not Available
Suspected suicide19.12.01.009; 08.04.01.0170.000427%Not Available
Therapeutic product effect decreased08.06.01.0500.006533%Not Available
The 3th Page    First    Pre   3    Total 3 Pages